FDA Investigator Samuel T Walker

Samuel T Walker has conducted inspections on 35 sites in 6 countries as of 21 Sep 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
35
Last Inspection Date:
21 Sep 2005
Investigator Role:
FDA Investigator
Redica ID:
100009219
Countries of Inspections:
Germany, Canada, United States of America, France, Sweden, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Samuel T Walker:
Alan P Kurtzberg, Alice S Tsao, Anissa M Vargas, Ann M Stewart, Anna M Alexander, Anthony A Charity, Anthony C Warchut, Arsen Karapetyan, Benton M Ketron, Bernice F Hirsch, Bijoy Panicker, Brandy N Lepage, Brian D Nicholson, Bryan L Mcguckin, Carl A Huffman, III, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Charanjeet Jassal, Charisse K Green, Charles I Ann, Charles R Cote, RIC, Christian Parra, Daryl A Dewoskin, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Devaughn Edwards, Dina K West, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donald G Gordon, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Elizabeth M Jacobson, Eric M Mueller, PharmD, Erin D Mccaffery, Evelyn Taha, Felix Maldonado, Frank Verni, Frederick F Razzaghi, Gary T Greco, George J Flynn, German Rivera, Gregson A Joseph, Guerlain Ulysse, Helen B Ricalde, Irina Gaberman, Ivan E Reyes, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, Jane C Chen, Janet A Rajan, John A Podsadowski, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose M Cayuela, Joseph J Vannelli, Joseph Maselli, Joseph Milcetic, Julie D Bringger, Karen L Kosar, Karen Takahashi, Katherine Szestypalow, Kelli F Dobilas, Kellie Leveille, Kenneth H Williams, Kevin A Gonzalez, Kevin P Foley, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lawrence W Farina, Leena Thomas, Lisa Hayka, LT Tamara J Henderson, Manhar R Patel, Margaret E Sarles, Marianela Aponte Cruz, Marie A Fadden, Marie Elena C Puleo, Mark R Mcclain, Matthew A Spataro, Mei Chiung Huang (Jo), Melinda L Rice, Michael A Charles, Michael L Casner, Michael Levin, Michael R Dominick, Michael S Araneta, Michele Perry Williams, Mindy M Chou, Mra Munizn, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Noreen Muñiz, Omotunde O Osunsanmi, Pal S Mayasandra, Paraluman S Leonin, Patrick L Wisor, Paul E Stein, Paul Mouris, Paula M Laplant, Perry T Nichols, Peter Abel, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Raymond T Oji, Richard Ferfoglia, Robert C Steyert, Rochelle L Cross, Ruben C Quintana, Saied A Asbagh, Sam Pepe, Samina S Khan, Sandra D Thompson, Sarah A Meehan, Sarah E Rhoades, Satheesh Thomas, Saundrea A Munroe, Shari L Kahn, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacie A Woods, Stella Yuen, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Syeda N Mahazabin, Tamara Brey, Tanya R Syffrard, Tara K Carmody, Tej Poonai, Theresa Kirkham (NMI), Thomas J Mooney, Thomas P Hansen, Tonya R Johnson, Tracy M Portelli, Uduak M Inokon, Valentino Fiorella, Verlinda A Narcisse, Viviana Matta, Winston R Alejo, Yumi J Hiramine, Yuyan Liang, Yvonne E Lozano

Samuel T Walker's Documents

Publish Date Document Type Title
March, 2001 FDA 483 E. Merck KGaA - Form 483, 2001-03-22
June, 2002 FDA 483 Novopharm Ltd. - Form 483, 2002-06-20
November, 2002 FDA 483 Barr Laboratories Inc. - Form 483, 2002-11-12
September, 2003 FDA 483 Silarx Pharmaceutical, Inc. - Form 483, 2003-09-17
February, 2003 EIR Novartis Pharmaceuticals Corp. - EIR, 2003-02-21
March, 2001 FDA 483 Response E. Merck KGaA - Form 483R, 2001-04-03
March, 2001 FDA 483 Merck KGaA - Form 483, 2001-03-16
June, 2001 EIR Barr Laboratories Inc. - EIR, 2001-06-29
November, 2002 EIR Barr Laboratories Inc. - EIR, 2002-11-12
January, 2000 FDA 483 Emisphere Technologies, Inc. - Form 483, 2000-01-21
November, 2002 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2003-02-26
November, 2000 FDA 483 Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483, 2000-11-09
March, 2001 EIR E. Merck - EIR, 2001-05-16
March, 2001 EIR E. Merck KGaA - EIR, 2001-06-07
January, 2000 FDA 483 Response Emisphere Technologies, Inc. - Form 483R, 2000-02-07
February, 2003 FDA 483 Response Novartis Pharmaceuticals Corp. - Form 483R, 2003-03-07
August, 2002 FDA 483 Silarx Pharmaceutical, Inc. - Form 483, 2002-08-08
March, 2001 FDA 483 Response E. Merck - Form 483R, 2001-04-12
July, 2003 FDA 483 Perrigo New York, Inc. - Form 483, 2003-07-10
February, 2003 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2003-02-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more